Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine

Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine

Streptococcus pneumoniae serotype 1 is one of the leading causes of invasive pneumococcal disease. However, this invasive serotype is hardly found in nasopharyngeal asymptomatic carriage and therefore large epidemiological studies are needed to assess the dynamics of serotype 1 infection. Within the...

Full description

Bibliographic Details
Main Authors:	Chinelo Ebruke, Anna Roca, Uzochukwu Egere, Ousainou Darboe, Philip C. Hill, Brian Greenwood, Brendan W. Wren, Richard A. Adegbola, Martin Antonio
Format:	Article
Language:	English
Published:	PeerJ Inc. 2015-04-01
Series:	PeerJ
Subjects:	Invasive pneumococcal disease Nasopharyngeal Swab Streptococcus pneumoniae serotype 1 Nasopharyngeal carriage 7-valent pneumococcal conjugate vaccine Gambia
Online Access:	https://peerj.com/articles/903.pdf

Similar Items

Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
by: John Njuma Libwea, et al.
Published: (2020-09-01)

Epidemiology, Nasopharyngeal Carriage, Serotype Prevalence, and Antibiotic Resistance of Streptococcus pneumoniae in Indonesia
by: Cissy B. Kartasasmita, et al.
Published: (2020-08-01)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
by: Ahmet Arvas, et al.
Published: (2017-08-01)

Pneumococcus nasopharyngeal carriage in children attending an academic hospital in Pretoria, South Africa, after the introduction of pneumococcal vaccine
by: Charity Newton, et al.
Published: (2019-10-01)

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
by: Germaine Hanquet, et al.
Published: (2022-01-01)

Methods for estimating the direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years in Matiari, Pakistan
by: Muhammad Imran Nisar, et al.
Published: (2021-01-01)

Trends in Asymptomatic Nasopharyngeal <i>Streptococcus pneumoniae</i> Carriage with qPCR and Culture Analysis
by: Julie-Anne Lemay, et al.
Published: (2022-10-01)

Pneumococcal disease in Thailand
by: Amgad Gamil, et al.
Published: (2021-01-01)

Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children – A randomized controlled trial
by: Xavier Sáez-Llorens, et al.
Published: (2017-06-01)

Impact of 10-valent Pneumococcal Conjugate Vaccine (PCV10) on nasopharyngeal carriage in children 2 years of age: Data from a four-year time series cross-sectional study from Pakistan
by: Muhammad Imran Nisar, et al.
Published: (2021-04-01)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01)

Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialResearch in context
by: Heidi Smith-Vaughan, et al.
Published: (2023-03-01)

Prevalence and risk factors for Staphylococcus aureus nasopharyngeal carriage during a PCV trial
by: Abdoulie Bojang, et al.
Published: (2017-08-01)

ANTIMICROBIAL SUSCEPTIBILITY OF S. PNEUMONIAE STRAINS ISOLATED FROM CHILDREN WITH NASOPHARYNGEAL CARRIAGE
by: Mariya Malcheva, et al.
Published: (2020-05-01)

A spitting image: molecular diagnostics applied to saliva enhance detection of Streptococcus pneumoniae and pneumococcal serotype carriage
by: Willem R. Miellet, et al.
Published: (2023-04-01)

Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned
by: S. F. La Vincente, et al.
Published: (2019-03-01)

Streptococcus pneumoniae serotype 19A: worldwide epidemiology
by: Raul Isturiz, et al.
Published: (2017-10-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

A longitudinal hospital-based epidemiology study to assess acute otitis media incidence and nasopharyngeal carriage in Korean children up to 24 months
by: Jin Lee, et al.
Published: (2020-12-01)

Mathematical assessment of the impact of cohort vaccination on pneumococcal carriage and serotype replacement
by: Tufail M. Malik, et al.
Published: (2021-05-01)

Comparison of Binax NOW urine antigen test and pneumococcal DNA assay using qPCR before and after nasopharyngeal swabbing in healthy Malawian children
by: E.A. Lees, et al.
Published: (2015-11-01)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014-02-01)

Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13
by: A. Løvlie, et al.
Published: (2020-01-01)

Non-pneumococcal mitis-group streptococci confound detection of pneumococcal capsular serotype-specific loci in upper respiratory tract
by: Maria da Gloria Carvalho, et al.
Published: (2013-06-01)

Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania
by: Mutagonda RF, et al.
Published: (2022-08-01)

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
by: Mikkelsen Malene B, et al.
Published: (2023-08-01)

Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development [version 2; peer review: 2 approved]
by: Ahmed H. Radhi, et al.
Published: (2023-12-01)

Clinical and Bacteriological Analysis of Pediatric Pneumococcal Meningitis after 13-Valent Pneumococcal Conjugate Vaccine Introduction in Japan
by: Erika Kurihara, et al.
Published: (2022-04-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
by: Salil Bendre, et al.
Published: (2024-02-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
by: Salil Bendre, et al.
Published: (2024-02-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

Dynamics of Antibiotic Resistance of <i>Streptococcus pneumoniae</i> in France: A Pediatric Prospective Nasopharyngeal Carriage Study from 2001 to 2022
by: Alexis Rybak, et al.
Published: (2023-06-01)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
by: Murat Sütçü, et al.
Published: (2017-02-01)

Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children
by: Giske Biesbroek, et al.
Published: (2014-02-01)

Pneumococcal serotype-specific IgG and opsonophagocytic activity in young Japanese patients with asplenia
by: Kenichi Takeshita, et al.
Published: (2021-10-01)

Impact of Pneumococcal Vaccination on Nasopharyngeal Carriage of <i>Streptococcus pneumoniae</i> and Microbiota Profiles in Preschool Children in South East Poland
by: Karolina Kielbik, et al.
Published: (2022-05-01)

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
by: Jeffrey Vietri, et al.
Published: (2020-01-01)

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis
by: Ioanna Papadatou, et al.
Published: (2023-05-01)

Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data
by: Strutton David R, et al.
Published: (2012-08-01)

Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation
by: Ron Dagan
Published: (2019-06-01)